vs
MVB FINANCIAL CORP(MVBF)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是MVB FINANCIAL CORP的1.9倍($69.8M vs $36.7M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 0.0%,领先384.0%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 2.8%)
MVB金融公司是总部位于美国西弗吉尼亚州的金融控股企业,主要提供商业与零售银行服务、财富管理、抵押贷款及存款产品,同时面向金融科技、游戏领域企业提供专项数字银行解决方案,服务覆盖美国中大西洋地区。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
MVBF vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.9倍
$36.7M
净利率更高
RIGL
高出384.0%
0.0%
两年增速更快
RIGL
近两年复合增速
2.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $36.7M | $69.8M |
| 净利润 | $0 | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 0.0% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益(稀释后) | $0.39 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MVBF
RIGL
| Q1 26 | $36.7M | — | ||
| Q4 25 | $39.1M | $69.8M | ||
| Q3 25 | $61.2M | $69.5M | ||
| Q2 25 | $33.7M | $101.7M | ||
| Q1 25 | $33.7M | $53.3M | ||
| Q4 24 | $46.2M | $57.6M | ||
| Q3 24 | $33.2M | $55.3M | ||
| Q2 24 | $34.7M | $36.8M |
净利润
MVBF
RIGL
| Q1 26 | $0 | — | ||
| Q4 25 | $4.2M | $268.1M | ||
| Q3 25 | $17.1M | $27.9M | ||
| Q2 25 | $2.0M | $59.6M | ||
| Q1 25 | $3.6M | $11.4M | ||
| Q4 24 | $9.4M | $14.3M | ||
| Q3 24 | $2.1M | $12.4M | ||
| Q2 24 | $4.1M | $-1.0M |
毛利率
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | 13.9% | 33.2% | ||
| Q3 25 | 38.3% | 40.9% | ||
| Q2 25 | 9.4% | 60.1% | ||
| Q1 25 | 14.3% | 23.9% | ||
| Q4 24 | 26.5% | 28.9% | ||
| Q3 24 | 8.4% | 25.4% | ||
| Q2 24 | 15.9% | 1.2% |
净利率
MVBF
RIGL
| Q1 26 | 0.0% | — | ||
| Q4 25 | 10.8% | 384.0% | ||
| Q3 25 | 28.0% | 40.2% | ||
| Q2 25 | 5.9% | 58.6% | ||
| Q1 25 | 10.6% | 21.5% | ||
| Q4 24 | 20.4% | 24.9% | ||
| Q3 24 | 6.3% | 22.5% | ||
| Q2 24 | 11.8% | -2.8% |
每股收益(稀释后)
MVBF
RIGL
| Q1 26 | $0.39 | — | ||
| Q4 25 | $0.32 | $14.11 | ||
| Q3 25 | $1.32 | $1.46 | ||
| Q2 25 | $0.15 | $3.28 | ||
| Q1 25 | $0.27 | $0.63 | ||
| Q4 24 | $0.72 | $0.82 | ||
| Q3 24 | $0.16 | $0.70 | ||
| Q2 24 | $0.31 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $334.9M | $391.5M |
| 总资产 | $3.3B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
MVBF
RIGL
| Q1 26 | $177.6M | — | ||
| Q4 25 | $244.1M | $155.0M | ||
| Q3 25 | $300.0M | $137.1M | ||
| Q2 25 | $399.4M | $108.4M | ||
| Q1 25 | $251.4M | $77.1M | ||
| Q4 24 | $317.9M | $77.3M | ||
| Q3 24 | $610.9M | $61.1M | ||
| Q2 24 | $455.5M | $49.1M |
总债务
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益
MVBF
RIGL
| Q1 26 | $334.9M | — | ||
| Q4 25 | $334.0M | $391.5M | ||
| Q3 25 | $327.8M | $117.6M | ||
| Q2 25 | $302.3M | $81.9M | ||
| Q1 25 | $310.1M | $18.6M | ||
| Q4 24 | $305.7M | $3.3M | ||
| Q3 24 | $303.1M | $-14.6M | ||
| Q2 24 | $296.6M | $-29.9M |
总资产
MVBF
RIGL
| Q1 26 | $3.3B | — | ||
| Q4 25 | $3.3B | $513.6M | ||
| Q3 25 | $3.2B | $242.5M | ||
| Q2 25 | $3.2B | $206.7M | ||
| Q1 25 | $3.0B | $176.0M | ||
| Q4 24 | $3.1B | $164.0M | ||
| Q3 24 | $3.4B | $139.4M | ||
| Q2 24 | $3.3B | $128.4M |
负债/权益比
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | $4.0M | $22.0M | ||
| Q3 25 | $-2.6M | $24.0M | ||
| Q2 25 | $7.4M | $30.5M | ||
| Q1 25 | $14.1M | $-893.0K | ||
| Q4 24 | $-285.0K | $14.5M | ||
| Q3 24 | $8.6M | $21.7M | ||
| Q2 24 | $26.9M | $302.0K |
自由现金流
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | $2.1M | — | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $7.2M | — | ||
| Q1 25 | $13.9M | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $26.6M | — |
自由现金流率
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | -5.8% | — | ||
| Q2 25 | 21.5% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | -4.1% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 76.7% | — |
资本支出强度
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.7% | — |
现金转化率
MVBF
RIGL
| Q1 26 | — | — | ||
| Q4 25 | 0.95× | 0.08× | ||
| Q3 25 | -0.15× | 0.86× | ||
| Q2 25 | 3.72× | 0.51× | ||
| Q1 25 | 3.95× | -0.08× | ||
| Q4 24 | -0.03× | 1.01× | ||
| Q3 24 | 4.15× | 1.75× | ||
| Q2 24 | 6.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MVBF
| Net Interest Income | $28.5M | 78% |
| Noninterest Income | $8.2M | 22% |
RIGL
暂无分部数据